Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial
PaperCitations, authors & open-access status
Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 39 citations, 2022 year and gold oa status.
39
Citations
2022
Year
gold
OA Status